Hence, we investigated whether PSGL-1 blockade could repolarize primary TAMs ex vivo and subsequently induce a proinflammatory response despite the presence of tumor cells and other TME-derived immune suppressive cells and factors. This evidence concerns the gene SELPLG and neoplasm.